Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics

Analytical Chemistry

Volumn 81, Issue 23, 2009, Pages 9755-9763

  Sussulini, Alessandra ^a   Prando, Alessandra ^a   Maretto, Danilo Althmann ^a   Poppi, Ronei Jesus ^a   Tasic, Ljubica ^a   Banzato, Cláudio Eduardo Muller ^a   Arruda, Marco Aurélio Zezzi ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; CHEMOMETRIC ANALYSIS; CHEMOMETRICS; CONTROL GROUPS; H NMR SPECTROSCOPY; HUMAN BLOODS; METABOLIC CHANGES; METABOLIC PROFILES; METABOLIC PROFILING; MOLECULAR CHANGES; MYO-INOSITOL; PATHOPHYSIOLOGICAL;

AMINO ACIDS; BLOOD; LITHIUM; METABOLITES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGANIC ACIDS; RESONANCE; SUGARS;

METABOLISM;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS;

EID: 73249130205     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac901502j     Document Type: Article

References (43)

1. Malhi, G. S.; Adams, D.; Lampe, L.; Paton, M.; O'Connor, N.; Newton, L. A.; Walter, G.; Taylor, A.; Porter, R.; Mulder, R. T.; Berk, M. Acta Psychiatr. Scand. 2009, 119 (Suppl. 439), 27-46.
2. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, text revision (DSM-IV-TR), 4th ed.; American Psychiatric Association: Washington, DC, 2000.
3. Depression and Bipolar Support Alliance. Perceptions and Impact of Bipolar Disorder: How Far Have We Really Come? Presented at the Fourth International Conference on Bipolar Disorder, Pittsburgh, PA, June 14-16, 2001.
4. Phillips, M. L.; Vieta, E. Schizophr. Bull. 2007, 33, 893-904.
5. Marmol, F. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32, 1761-1771.
6. Oswald, P.; Souery, D.; Kasper, S.; Lecrubier, Y.; Montgomery, S.; Wyckaert, S.; Zohar, J.; Mendlewicz, J. Eur. Neuropsychopharmacol. 2007, 17, 687-695.
7. Gitlin, M. Mol. Psychiatry 2006, 11, 227-240.
8. Maj, M. Bipolar Disord. 2003, 5, 180-188.
9. Detera-Wadleigh, S. D.; MacMahon, F. J. Biol. Psychiatry 2006, 60, 106-114.
10. Lenz, E. M.; Wilson, I. D. J. Proteome Res. 2007, 6, 443-458.
11. Moco, S.; Bino, R. J.; de Vos, R. C. H.; Vervoort, J. Trends Anal. Chem. 2007, 26, 855-866.
12. Wishart, D. S. Trends Anal. Chem. 2008, 27, 228-237.
13. Maher, A. D.; Crockford, D.; Toft, H.; Malmodin, D.; Faber, J. H.; McCarthy, M. I.; Barrett, A.; Allen, M.; Walker, M.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Anal. Chem. 2008, 80, 7354-7362.
14. Dunn, W. B.; Ellis, D. I. Trends Anal. Chem. 2005, 24, 285-294.
15. Kaddurah-Daouk, R.; Krishnan, K. R. R. Neuropsychopharmacology 2009, 34, 173-186.
16. Nicholson, J. K.; Lindon, J. C. Nature 2008, 455, 1054-1056.
17. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Nat. Rev. Drug Discovery 2002, 1, 153-161.
18. Sanacora, G.; Rothman, D.; Krystal, J. H. Neuroscientist 1999, 5, 192-196.
19. Öngür, D.; Prescot, A. P.; Jensen, J. E.; Cohen, B. M.; Renshaw, P. F. Psychiatry Res.: Neuroimaging 2009, 172, 44-48.
20. Bertolino, A.; Frye, M.; Callicott, J. H.; Mattay, V. S.; Rakow, R.; Shelton-Repella, J.; Post, R.; Weinberger, D. R. Biol. Psychiatry 2003, 53, 906-913.
21. Lan, M. J.; McLoughlin, G. A.; Griffin, J. L.; Tsang, T. M.; Huang, J. T. J.; Yuan, P.; Manji, H.; Holmes, E.; Bahn, S. Mol. Psychiatry 2009, 14, 269-279.
22. Teahan, O.; Gamble, S.; Holmes, E.; Waxman, J.; Nicholson, J. K.; Bevan, C.; Keun, H. C. Anal. Chem. 2006, 78, 4307-4318.
23. Diaz, F. J.; James, D.; Botts, S.; Maw, L.; Susce, M. T.; de Leon, J. Bipolar Disord. 2009, 11, 154-165.
24. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Nat. Biotechnol. 2008, 26, 162-164.
25. Madison Metabolomics Consortium Database; University of Wisconsin: Madison, WI. http://mmcd.nmrfam.wisc.edu/. (Accessed July 20, 2009).
26. Nørgaard, L. The iToolbox for MATLAB; KVL: Frederiksberg, Denmark. http://www.models.life.ku.dk. (Accessed July 27, 2009).
27. Sena, M. M.; Chaudhry, Z. F.; Collins, C. H.; Poppi, R. J. J. Pharm. Biomed. Anal. 2004, 36, 743-749.
28. Kato, T. Neurosci. Res. 2001, 40, 105-113.
29. Wold, S.; Antii, H.; Lindgren, F.; Ohman, J. Chemom. Intell. Lab. Syst. 1998, 44, 175-185.
30. Trygg, J.; Holmes, E.; Lundstedt, T. J. Proteome Res. 2007, 6, 469-479.
31. PLS Toolbox 3.5 for MATLAB; Eigenvector Research: Wenatchee, WA, 2005.
32. de Oliveira, P. R.; Tasic, L.; Rocco, S. A.; Rittner, R. Magn. Reson. Chem. 2006, 44, 790-796.
33. Nicholson, J. K.; Foxall, P. J. D.; Spraul, M.; Farrant, R. D.; Lindon, J. C. Anal. Chem. 1995, 67, 793-811.
34. Tang, H.; Wang, Y.; Nicholson, J. K.; Lindon, J. C. Anal. Biochem. 2004, 325, 260-272.
35. Miller, J. C.; Miller, J. N. Statistics and Chemometrics for Analytical Chemistry, 4th ed.; Pearson Prentice Hall: Upper Saddle River, NJ, 2005.
36. Atmaca, M.; Kuloglu, M.; Tezcan, E.; Ustundag, B.; Bayik, Y. Neuropsychobiology 2002, 46, 176-179.
37. Ozbulut, O.; Guler, O.; Kurt, E.; Alatas, G.; Serteser, M.; Gecici, O. Neurol. Psychiatry Brain Res. 2007, 14, 127-130.
38. Schwarz, E.; Prabakaran, S.; Whitfield, P.; Major, H.; Leweke, F. M.; Koethe, D.; McKenna, P.; Bahn, S. J. Proteome Res. 2008, 7, 4266-4277.
39. Craig, W. Y.; Palomaki, G. E.; Haddow, J. E. Br. Med. J. 1989, 298, 784-788.
40. Siegel, G. J.; Albers, R. W.; Brady, S.; Price, D. L. Basic Neurochemistry: Moleclular, Cellular and Medical Aspects, 2nd ed.; Academic Press: London, 2006.
41. Stoll, A. L.; Sachs, G. S.; Cohen, B. M.; Lafer, B.; Christensen, J. D.; Renshaw, P. F. Biol. Psychiatry 1996, 40, 382-388.
42. Yildiz-Yesiloglu, A.; Ankerst, D. P. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006, 30, 969-995.
43. Forester, B. P.; Finn, C. T.; Berlow, Y. A.; Wardrop, M.; Renshaw, P. F.; Moore, C. M. Bipolar Disord. 2008, 10, 691-700.